Ghost Tree Capital, LLC / AXSM
Ghost Tree Capital, LLC’s Axsome Therapeutics Inc. Position
Does Ghost Tree Capital, LLC own Axsome Therapeutics Inc. (AXSM)? Yes — 135.0K shares worth $12M (+3.66% of its 13F portfolio) as of Q3 2024, down from 150.0K shares the prior filed quarter.
Position Value
$12M
Q3 2024
Shares
135.0K
% of Portfolio
+3.66%
Quarters Held
17
currently held
Position History AXSM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 135.0K | $12M | +3.66% |
| Q2 2024 | 150.0K | $12M | +3.78% |
| Q1 2024 | 210.0K | $17M | +4.64% |
| Q4 2023 | 165.0K | $13M | +4.29% |
| Q3 2023 | 110.0K | $8M | +2.53% |
| Q2 2023 | 110.0K | $8M | +2.61% |
| Q1 2023 | 225.0K | $14M | +4.10% |
| Q4 2022 | 235.0K | $18M | +7.74% |
| Q3 2022 | 300.0K | $13M | +3.76% |
| Q2 2022 | 225.0K | $9M | +4.49% |
| Q1 2022 | 94.5K | $4M | +0.85% |
| Q2 2020 | 100.0K | $8M | +2.17% |
| Q1 2020 | 215.0K | $13M | +3.35% |
| Q4 2019 | 200.0K | $21M | +3.91% |
| Q3 2019 | 675.0K | $14M | +3.47% |
| Q2 2019 | 850.0K | $22M | +4.58% |
| Q1 2019 | 310.0K | $4M | +1.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of AXSM.